-
Regular coffee consumption is associated with a prominent decrease in fatal or metastatic prostate cancer.
-
In a small 5-week pilot trial examining the use of magnesium for the treatment of hot flashes, women with a history of breast cancer experienced improvements in hot flash frequency and severity, but no significant impact on overall quality of life.
-
A very low energy diet followed by a weight maintenance program results in significant improvements in weight, obstructive sleep apnea, metabolic factors, and quality of life for at least a year.
-
This systematic review searched for studies using any methodology that measured outcomes in cancer patients who received energy healing techniques. Some evidence of improvements in psychosocial outcomes was found, but the methodological deficiencies in the original studies undermined confidence in their findings. The reviewers call for further research studies designed according to high-quality research standards.
-
Sleep disruption in menopause is common. one-fourth to one-half of all women will note some sleep complaint during menopause, as compared to approximately 15% in the general population.
-
Vitamin D deficiency was found to be present in almost all patients entering with acute myocardial infarctions in a 20-hospital multicenter study.
-
Family history of cancer changes significantly between the ages of 30 and 50 years. Therefore, it is recommended that family history should be updated at least every 5 to 10 years to appropriately inform recommendations for cancer screening.
-
It comes as no surprise that when patients do not take their blood pressure (BP) medication, a lapse in BP control is anticipated. On the other hand, when a patient presents with an elevated BP and acknowledges omitted doses, it is difficult to be sure whether the observed elevation in BP is solely due to recent omissions, an underlying worsening of BP (requiring an augmentation rather than just simple restoration of treatment), rebound BP elevation, or some combination of these elements.
-
A systematic review covering 48 years gives pregabalin (Lyrica) Level A evidence for the treatment of diabetic neuropathy. Gabapentin, sodium valproate, amitriptyline, venlafaxine, and duloxetine may be as effective but only receive a Level B recommendation based on the quality of the studies.
-
Interpret the rhythm strip shown above. Does it represent 2nd degree AV block, Mobitz Type II? Can you be sure?